91,000 Bottles of Chronic Kidney Disease Drug Recalled Over Carcinogens

Three different strengths of cinacalcet hydrochloride tablets were confirmed under recall by the FDA this week due to the presence of nitrosamines.

Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan in New York City on July 23, 2024. Spencer Platt/Getty Images

Nearly 100,000 bottles of a type of drug used to treat chronic kidney disease and other conditions are being recalled due to possible carcinogens, according to a notice published by the Food and Drug Administration this week.

In three separate notices published this week on the FDA’s website, a combined 91,824 bottles of cinacalcet hydrochloride tablets in different strengths are being recalled due to the presence of a nitrosamine, N-nitroso-cinacalcet, found to be above the FDA’s acceptable daily intake levels.